Selected research
Market Structure
Global CAR-T Cellular Immunotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global CAR-T Cellular Immunotherapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for CAR-T Cellular Immunotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for CAR-T Cellular Immunotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CAR-T Cellular Immunotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for CAR-T Cellular Immunotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of CAR-T Cellular Immunotherapy include Novartis, Gilead Sciences, Fosun Kite Biotechnology and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global CAR-T Cellular Immunotherapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of CAR-T Cellular Immunotherapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents CAR-T Cellular Immunotherapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the CAR-T Cellular Immunotherapy market size, projected growth trends, production technologies, key applications, and end-use industries.
CAR-T Cellular Immunotherapy Segment by Company
Novartis
Gilead Sciences
Fosun Kite Biotechnology
Bristol-Myers Squibb
CAR-T Cellular Immunotherapy Segment by Type
Allogeneic
Autologous
CAR-T Cellular Immunotherapy Segment by Application
Hospital
Pharmacy
Other
CAR-T Cellular Immunotherapy Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CAR-T Cellular Immunotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CAR-T Cellular Immunotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CAR-T Cellular Immunotherapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of CAR-T Cellular Immunotherapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global CAR-T Cellular Immunotherapy industry.
Chapter 3: Detailed analysis of CAR-T Cellular Immunotherapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CAR-T Cellular Immunotherapyrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Allogeneic
- Autologous
Applications
- Hospital
- Pharmacy
- Other
Companies covered
- Novartis
- Gilead Sciences
- Fosun Kite Biotechnology
- Bristol-Myers Squibb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global CAR-T Cellular Immunotherapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Allogeneic
- 1.2.3 Autologous
- 1.3 Market Analysis by Application
- 1.3.1 Global CAR-T Cellular Immunotherapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Pharmacy
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global CAR-T Cellular Immunotherapy Growth Trends by Region
- 1.5.1 Global CAR-T Cellular Immunotherapy Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 CAR-T Cellular Immunotherapy Market Size by Region (2021-2026)
- 1.5.3 CAR-T Cellular Immunotherapy Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global CAR-T Cellular Immunotherapy Market Dynamics
- 2.1 CAR-T Cellular Immunotherapy Industry Trends
- 2.2 CAR-T Cellular Immunotherapy Industry Drivers
- 2.3 CAR-T Cellular Immunotherapy Industry Opportunities and Challenges
- 2.4 CAR-T Cellular Immunotherapy Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global CAR-T Cellular Immunotherapy Revenue by Company (2021-2026)
- 3.2 Global CAR-T Cellular Immunotherapy Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global CAR-T Cellular Immunotherapy Key Company Head office and Area Served
- 3.4 Global CAR-T Cellular Immunotherapy Company, Product Type & Application
- 3.5 Global CAR-T Cellular Immunotherapy Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global CAR-T Cellular Immunotherapy Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 CAR-T Cellular Immunotherapy Players Market Share by Revenue in 2025
- 3.6.3 2025 CAR-T Cellular Immunotherapy Tier 1, Tier 2, and Tier 3
4 CAR-T Cellular Immunotherapy Market by Type
- 4.1 Global CAR-T Cellular Immunotherapy Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global CAR-T Cellular Immunotherapy Market Size by Type (2021-2032)
- 4.3 Global CAR-T Cellular Immunotherapy Market Size Share by Type (2021-2032)
5 CAR-T Cellular Immunotherapy Market by Application
- 5.1 Global CAR-T Cellular Immunotherapy Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global CAR-T Cellular Immunotherapy Market Size by Application (2021-2032)
- 5.3 Global CAR-T Cellular Immunotherapy Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Novartis
- 6.1.1 Novartis Company Information
- 6.1.2 Novartis Business Overview
- 6.1.3 Novartis CAR-T Cellular Immunotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Novartis CAR-T Cellular Immunotherapy Product Portfolio
- 6.1.5 Novartis Recent Developments
- 6.2 Gilead Sciences
- 6.2.1 Gilead Sciences Company Information
- 6.2.2 Gilead Sciences Business Overview
- 6.2.3 Gilead Sciences CAR-T Cellular Immunotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Gilead Sciences CAR-T Cellular Immunotherapy Product Portfolio
- 6.2.5 Gilead Sciences Recent Developments
- 6.3 Fosun Kite Biotechnology
- 6.3.1 Fosun Kite Biotechnology Company Information
- 6.3.2 Fosun Kite Biotechnology Business Overview
- 6.3.3 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Product Portfolio
- 6.3.5 Fosun Kite Biotechnology Recent Developments
- 6.4 Bristol-Myers Squibb
- 6.4.1 Bristol-Myers Squibb Company Information
- 6.4.2 Bristol-Myers Squibb Business Overview
- 6.4.3 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Product Portfolio
- 6.4.5 Bristol-Myers Squibb Recent Developments
7 North America
- 7.1 North America CAR-T Cellular Immunotherapy Market Size (2021-2032)
- 7.2 North America CAR-T Cellular Immunotherapy Market Size by Type
- 7.2.1 North America CAR-T Cellular Immunotherapy Market Size by Type (2021-2026)
- 7.2.2 North America CAR-T Cellular Immunotherapy Market Size by Type (2027-2032)
- 7.2.3 North America CAR-T Cellular Immunotherapy Market Share by Type (2021-2032)
- 7.3 North America CAR-T Cellular Immunotherapy Market Size by Application
- 7.3.1 North America CAR-T Cellular Immunotherapy Market Size by Application (2021-2026)
- 7.3.2 North America CAR-T Cellular Immunotherapy Market Size by Application (2027-2032)
- 7.3.3 North America CAR-T Cellular Immunotherapy Market Share by Application (2021-2032)
- 7.4 North America CAR-T Cellular Immunotherapy Market Size by Country
- 7.4.1 North America CAR-T Cellular Immunotherapy Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America CAR-T Cellular Immunotherapy Market Size by Country (2021-2026)
- 7.4.3 North America CAR-T Cellular Immunotherapy Market Size by Country (2027-2032)
- 7.4.4 North America CAR-T Cellular Immunotherapy Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe CAR-T Cellular Immunotherapy Market Size (2021-2032)
- 8.2 Europe CAR-T Cellular Immunotherapy Market Size by Type
- 8.2.1 Europe CAR-T Cellular Immunotherapy Market Size by Type (2021-2026)
- 8.2.2 Europe CAR-T Cellular Immunotherapy Market Size by Type (2027-2032)
- 8.2.3 Europe CAR-T Cellular Immunotherapy Market Share by Type (2021-2032)
- 8.3 Europe CAR-T Cellular Immunotherapy Market Size by Application
- 8.3.1 Europe CAR-T Cellular Immunotherapy Market Size by Application (2021-2026)
- 8.3.2 Europe CAR-T Cellular Immunotherapy Market Size by Application (2027-2032)
- 8.3.3 Europe CAR-T Cellular Immunotherapy Market Share by Application (2021-2032)
- 8.4 Europe CAR-T Cellular Immunotherapy Market Size by Country
- 8.4.1 Europe CAR-T Cellular Immunotherapy Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe CAR-T Cellular Immunotherapy Market Size by Country (2021-2026)
- 8.4.3 Europe CAR-T Cellular Immunotherapy Market Size by Country (2027-2032)
- 8.4.4 Europe CAR-T Cellular Immunotherapy Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China CAR-T Cellular Immunotherapy Market Size (2021-2032)
- 9.2 China CAR-T Cellular Immunotherapy Market Size by Type
- 9.2.1 China CAR-T Cellular Immunotherapy Market Size by Type (2021-2026)
- 9.2.2 China CAR-T Cellular Immunotherapy Market Size by Type (2027-2032)
- 9.2.3 China CAR-T Cellular Immunotherapy Market Share by Type (2021-2032)
- 9.3 China CAR-T Cellular Immunotherapy Market Size by Application
- 9.3.1 China CAR-T Cellular Immunotherapy Market Size by Application (2021-2026)
- 9.3.2 China CAR-T Cellular Immunotherapy Market Size by Application (2027-2032)
- 9.3.3 China CAR-T Cellular Immunotherapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia CAR-T Cellular Immunotherapy Market Size (2021-2032)
- 10.2 Asia CAR-T Cellular Immunotherapy Market Size by Type
- 10.2.1 Asia CAR-T Cellular Immunotherapy Market Size by Type (2021-2026)
- 10.2.2 Asia CAR-T Cellular Immunotherapy Market Size by Type (2027-2032)
- 10.2.3 Asia CAR-T Cellular Immunotherapy Market Share by Type (2021-2032)
- 10.3 Asia CAR-T Cellular Immunotherapy Market Size by Application
- 10.3.1 Asia CAR-T Cellular Immunotherapy Market Size by Application (2021-2026)
- 10.3.2 Asia CAR-T Cellular Immunotherapy Market Size by Application (2027-2032)
- 10.3.3 Asia CAR-T Cellular Immunotherapy Market Share by Application (2021-2032)
- 10.4 Asia CAR-T Cellular Immunotherapy Market Size by Country
- 10.4.1 Asia CAR-T Cellular Immunotherapy Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia CAR-T Cellular Immunotherapy Market Size by Country (2021-2026)
- 10.4.3 Asia CAR-T Cellular Immunotherapy Market Size by Country (2027-2032)
- 10.4.4 Asia CAR-T Cellular Immunotherapy Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Size (2021-2032)
- 11.2 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Type
- 11.2.1 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Application
- 11.3.1 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Country
- 11.4.1 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa CAR-T Cellular Immunotherapy Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst